Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.26%178.59M | 3.25%660.94M | -0.71%169.04M | 2.24%163.7M | 5.48%166.22M | 6.43%161.97M | 13.30%640.14M | 9.41%170.25M | 10.40%160.11M | 13.10%157.59M |
Net interest income | 3.45%149.07M | 4.92%588.44M | 3.90%149.14M | 4.29%147.88M | 5.50%147.33M | 6.04%144.1M | 16.34%560.87M | 6.11%143.54M | 12.08%141.79M | 21.33%139.64M |
-Net interest income | 3.16%189.22M | 15.63%750.28M | 7.93%190.16M | 14.07%189.03M | 18.78%187.66M | 23.12%183.43M | 25.86%648.88M | 20.91%176.2M | 23.04%165.71M | 29.26%157.99M |
-Interest income from loans and lease | 2.55%153.41M | 10.61%613.6M | 4.41%155.34M | 8.63%154.41M | 13.83%154.26M | 16.59%149.59M | 20.55%554.74M | 19.02%148.78M | 22.28%142.14M | 21.70%135.52M |
-Interest income from securities | 5.86%35.81M | 45.19%136.68M | 26.98%34.82M | 46.89%34.62M | 48.65%33.4M | 63.65%33.83M | 69.89%94.14M | 32.31%27.42M | 27.85%23.57M | 106.81%22.47M |
-Total interest expense | 2.10%40.15M | 83.88%161.84M | 25.62%41.03M | 72.05%41.16M | 119.87%40.33M | 200.46%39.32M | 162.77%88.01M | 212.66%32.66M | 192.97%23.92M | 157.35%18.34M |
-Interest expense for deposit | -1.36%36.29M | 97.83%150.28M | 39.65%37.33M | 84.18%38.34M | 137.57%37.81M | 194.41%36.79M | 135.63%75.97M | 160.38%26.73M | 160.66%20.82M | 129.21%15.92M |
-Interest expense for long term debt and capital securities | 52.41%3.86M | 26.04%11.02M | -5.83%3.15M | 18.41%2.81M | 3.83%2.52M | 328.43%2.53M | 596.89%8.74M | 1,779.78%3.35M | 1,233.71%2.37M | 1,219.57%2.43M |
Non interest income | 65.16%29.52M | -8.54%72.5M | -25.48%19.9M | -13.63%15.83M | 5.32%18.9M | 9.66%17.87M | -4.42%79.27M | 31.42%26.71M | -1.02%18.32M | -25.98%17.95M |
-Fees and commissions | 66.14%29.21M | -3.18%70.43M | -4.74%19.11M | -15.53%15.23M | -1.19%18.51M | 10.40%17.58M | -5.54%72.75M | -0.10%20.06M | -0.89%18.03M | -2.69%18.73M |
-Other non interest income | 3.04%305K | -72.96%2.08M | -88.10%791K | 102.37%597K | 7.71%391K | -20.00%296K | 24.39%7.68M | 1,259.30%6.65M | -8.39%295K | -92.73%363K |
-Gain loss on sale of assets | ---- | 99.39%-7K | --0 | --0 | --0 | ---7K | -365.18%-1.15M | --0 | --0 | ---1.15M |
Credit losses provision | -69.88%-25.69M | -35.64%-82.25M | -53.10%-30.19M | -30.00%-21.36M | -3.57%-15.58M | -60.10%-15.12M | -151.41%-60.64M | -125.18%-19.72M | -130.76%-16.43M | -124.84%-15.04M |
Non interest expense | 18.39%93.45M | 3.40%324.94M | 4.83%86.06M | 3.57%80.56M | 3.42%79.38M | 1.70%78.94M | 5.87%314.26M | 4.31%82.1M | 3.18%77.78M | 4.73%76.76M |
Occupancy and equipment | 3.48%14.82M | -0.19%59.12M | -2.83%15.28M | 1.59%15.12M | 0.22%14.39M | 0.46%14.32M | 15.45%59.24M | 13.22%15.73M | 17.80%14.89M | 11.67%14.36M |
Professional expense and contract services expense | ---- | 0.60%18.88M | 33.83%4.78M | 3.45%4.98M | -3.80%5.12M | -20.93%4M | -24.47%18.76M | -36.44%3.57M | -25.32%4.81M | -27.75%5.32M |
Selling and administrative expenses | 71.88%77.6M | 3.21%180.68M | 3.68%48.02M | 2.40%43.76M | 3.37%44.03M | 3.35%45.15M | 8.69%175.06M | 9.98%46.31M | 7.07%42.73M | 8.29%42.59M |
-General and administrative expense | 81.44%77.6M | 2.79%170.96M | 3.93%45.6M | 1.88%41.29M | 2.60%41.58M | 2.69%42.77M | 8.83%166.32M | 10.56%43.87M | 6.69%40.53M | 8.07%40.53M |
-Selling and marketing expense | ---- | 11.11%9.71M | -0.74%2.42M | 11.92%2.47M | 18.52%2.45M | 16.85%2.38M | 6.10%8.74M | 0.58%2.44M | 14.54%2.21M | 12.92%2.06M |
Other non-interest expense | -93.35%1.03M | 8.29%66.26M | 9.07%17.98M | 8.79%16.7M | 9.37%15.84M | 5.82%15.46M | 2.65%61.19M | -3.53%16.49M | -6.35%15.35M | 5.44%14.49M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | 0 | ||||||||
Gain on extinguishment of debt | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | -12.47%59.45M | -4.34%253.75M | -22.86%52.79M | -6.24%61.78M | 8.32%71.26M | 4.27%67.92M | 8.66%265.25M | 0.43%68.43M | 5.41%65.9M | 10.83%65.79M |
Income tax | -23.86%13.88M | -33.34%55.58M | -88.83%2.44M | -29.68%14.78M | -6.86%20.13M | -3.59%18.23M | 7.08%83.38M | 0.29%21.84M | 2.07%21.03M | 14.21%21.61M |
Earnings from equity interest net of tax | ||||||||||
Net income | -8.29%45.57M | 8.96%198.17M | 8.05%50.35M | 4.74%47M | 15.75%51.13M | 7.49%49.69M | 9.40%181.87M | 0.50%46.6M | 7.05%44.87M | 9.25%44.17M |
Net Income continuous operations | -8.29%45.57M | 8.96%198.17M | 8.05%50.35M | 4.74%47M | 15.75%51.13M | 7.49%49.69M | 9.40%181.87M | 0.50%46.6M | 7.05%44.87M | 9.25%44.17M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -8.29%45.57M | 8.96%198.17M | 8.05%50.35M | 4.74%47M | 15.75%51.13M | 7.49%49.69M | 9.40%181.87M | 0.50%46.6M | 7.05%44.87M | 9.25%44.17M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -8.29%45.57M | 8.96%198.17M | 8.05%50.35M | 4.74%47M | 15.75%51.13M | 7.49%49.69M | 9.40%181.87M | 0.50%46.6M | 7.05%44.87M | 9.25%44.17M |
Basic earnings per share | -4.72%1.01 | 10.39%4.25 | 11.11%1.1 | 6.32%1.01 | 17.20%1.09 | 9.28%1.06 | 11.27%3.85 | 2.06%0.99 | 7.95%0.95 | 10.71%0.93 |
Diluted earnings per share | -4.76%1 | 10.44%4.23 | 11.22%1.09 | 5.26%1 | 16.13%1.08 | 9.38%1.05 | 11.34%3.83 | 1.03%0.98 | 9.20%0.95 | 10.71%0.93 |
Dividend per share | 20.00%0.3 | 13.64%1 | 13.64%0.25 | 13.64%0.25 | 13.64%0.25 | 13.64%0.25 | 25.71%0.88 | 10.00%0.22 | 10.00%0.22 | 46.67%0.22 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |